<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="10.1038/s41541-020-0205-6 : Perspective Review of data and knowledge gaps regarding" exact="yellow fever" post="vaccine-induced immunity and duration of protection http://orcid.org/0000-0002-1446-4071StaplesJ. Erinestaples@cdc.gov1BarrettAlan D."/>
 <result pre="detection of antibodies is used to denote protective immunity following" exact="measles" post="vaccination, it also has been documented that individuals lacking"/>
 <result pre="can develop secondary immune response with revaccination or exposure to" exact="measles" post="virus suggesting that alternative types of immunity exist42. Currently,"/>
 <result pre="additional doses of YF vaccine31. Table 1 Seropositivity following full-dose" exact="yellow fever" post="(YF) vaccination in adults. Study vaccine Population Type Test"/>
 <result pre="post-vaccination lacked detectable neutralizing antibodies. Table 2 Seropositivity following full-dose" exact="yellow fever" post="(YF) vaccination in children. Study Vaccine Population Type Test"/>
 <result pre="29â€&quot;94% (median: 68%) in Africa67. The current large outbreaks of" exact="measles" post="throughout the world, including in YF endemic areas where"/>
 <result pre="Vaccines. References References 1.JohanssonMAVasconcelosPFStaplesJEThe whole iceberg: estimating the incidence of" exact="yellow fever" post="virus infection from the number of severe casesTrans. R."/>
 <result pre="Soc. Trop. Med. Hyg.201410848248724980556 2.Ho, Y. L. et al. Severe" exact="yellow fever" post="in Brazil: clinical characteristics and management. J. Travel Med.26,"/>
 <result pre="salud publ. = Pan Am. J. Public Health201943e29 6.ShearerFMet al.Global" exact="yellow fever" post="vaccination coverage from 1970 to 2016: an adjusted retrospective"/>
 <result pre="(Elsevier Inc., 2018). 9.CaseyRMet al.Immunogenicity of fractional-dose vaccine during a" exact="yellow fever" post="outbreakâ€&quot;final reportN. Engl. J. Med.201938144445429443626 10.Advisory Committee on Immunization"/>
 <result pre="inoculatedTrans. R. Soc. Trop. Med. Hyg.194438231234 14.CourtoisG[Duration of immunity after" exact="yellow fever" post="vaccination]Ann. Soc. Belg. Med. trop.195434912 15.DickGWGeeFLImmunity to yellow fever"/>
 <result pre="after yellow fever vaccination]Ann. Soc. Belg. Med. trop.195434912 15.DickGWGeeFLImmunity to" exact="yellow fever" post="nine years after vaccination with 17D vaccineTrans. R. Soc."/>
 <result pre="R. Soc. Trop. Med. Hyg.19524644945814958824 16.GrootHRiberiroRBNeutralizing and haemagglutination-inhibiting antibodies to" exact="yellow fever" post="17 years after vaccination with 17D vaccineBull. World Health"/>
 <result pre="17.RosenzweigECBabioneRWWissemanCLJr.Immunological studies with group B arthropod-borne viruses. IV. Persistence of" exact="yellow fever" post="antibodies following vaccination with 17D strain yellow fever vaccineAm."/>
 <result pre="Persistence of yellow fever antibodies following vaccination with 17D strain" exact="yellow fever" post="vaccineAm. J. Trop. Med. Hyg.19631223023513975014 18.GotuzzoEYactayoSCordovaEEfficacy and duration of"/>
 <result pre="J. Trop. Med. Hyg.19631223023513975014 18.GotuzzoEYactayoSCordovaEEfficacy and duration of immunity after" exact="yellow fever" post="vaccination: systematic review on the need for a booster"/>
 <result pre="Vaccines.http://www.who.int/entity/immunization/sage/meetings/2013/april /1_Background_Paper_Yellow_Fever_Vaccines.pdf?ua=1 (2013). 20.World Health Organization. Vaccines and vaccination against" exact="yellow fever." post="WHO position paperâ€&quot;June 2013. Wkly. Epidemiol. Rec.88, 269â€&quot;283 (2013)."/>
 <result pre="decision too feverish?Clin. Microbiol. Infect.20131988588623927031 24.Plotkin, S. A. Ten yearly" exact="yellow fever" post="booster vaccinations may still be justified. J. Travel Med.25,"/>
 <result pre="26.AmannaIJSlifkaMKQuestions regarding the safety and duration of immunity following live" exact="yellow fever" post="vaccinationExpert Rev. Vaccines2016151519153327267203 27.KarekoBWet al.Persistence of neutralizing antibody responses"/>
 <result pre="vaccinationExpert Rev. Vaccines2016151519153327267203 27.KarekoBWet al.Persistence of neutralizing antibody responses among" exact="yellow fever" post="virus 17D vaccinees living in a nonendemic settingJ. Infect."/>
 <result pre="group for studies on yellow fever.Duration of post-vaccination immunity against" exact="yellow fever" post="in adultsVaccine2014324977498425090646 29.collab: Collaborative group for studies on yellow"/>
 <result pre="fever.Duration of immunity in recipients of two doses of 17DD" exact="yellow fever" post="vaccineVaccine2019375129513531171393 30.Campi-AzevedoACet al.17DD yellow fever revaccination and heightened long-term"/>
 <result pre="of two doses of 17DD yellow fever vaccineVaccine2019375129513531171393 30.Campi-AzevedoACet al.17DD" exact="yellow fever" post="revaccination and heightened long-term immunity in populations of disease-endemic"/>
 <result pre="disease-endemic areas, BrazilEmerg. Infect. Dis.2019251511152131298654 31.MiyajiKTet al.Prevalence and titers of" exact="yellow fever" post="virus neutralizing antibodies in previously vaccinated adultsRev. Inst. Med."/>
 <result pre="Sao Paulo201759e228380113 32.de Menezes MartinsRet al.Duration of post-vaccination immunity to" exact="yellow fever" post="in volunteers eight years after a dose-response studyVaccine2018364112411729784469 33.de"/>
 <result pre="dose-response studyVaccine2018364112411729784469 33.de NoronhaTGet al.Duration of post-vaccination humoral immunity against" exact="yellow fever" post="in childrenVaccine2019377147715431590934 34.DomingoCet al.Long-term immunity against yellow fever in"/>
 <result pre="immunity against yellow fever in childrenVaccine2019377147715431590934 34.DomingoCet al.Long-term immunity against" exact="yellow fever" post="in children vaccinated during infancy: a longitudinal cohort studyLancet"/>
 <result pre="WHO consultation on immunological endpoints for evaluation of new Japanese" exact="encephalitis" post="vaccines, WHO, Geneva, 2â€&quot;3 September, 2004Vaccine2005235205521116055233 38.RoehrigJTHombachJBarrettADGuidelines for plaque-reduction"/>
 <result pre="Veit, O. &amp;amp; Chen, L. H. Waning immunity after single-dose" exact="yellow fever" post="vaccination: who needs a second shot? J. Travel Med.26,"/>
 <result pre="M.) 1001â€&quot;1030 (Elsevier Inc., 2018). 42.ErdmanDDHeathJLWatsonJCMarkowitzLEBelliniWJImmunoglobulin M antibody response to" exact="measles" post="virus following primary and secondary vaccination and natural virus"/>
 <result pre="43.HepburnMJet al.Neutralizing antibody response to booster vaccination with the 17d" exact="yellow fever" post="vaccineVaccine2006242843284916494976 44.Brasil Ministerio da Saude. [Yellow Fever Seasonal Monitoring"/>
 <result pre="Fever Seasonal Monitoring Brasilâ€&quot;2017/2018]https://portalarquivos2.saude.gov.br/images/pdf/2018/outubro/08/Informe-FA.pdf (2018). 45.CamaraFPde CarvalhoLMGomesALDemographic profile of sylvatic" exact="yellow fever" post="in Brazil from 1973 to 2008Trans. R. Soc. Trop."/>
 <result pre="Yellow Fever].http://www.saude.mg.gov.br/fornecimento-de-medicamentos/story/10284-informe-epidemiologico-da-febre-amarela-27-02 (2018). 48.TuboiSHCostaZGda Costa VasconcelosPFHatchDClinical and epidemiological characteristics of" exact="yellow fever" post="in Brazil: analysis of reported cases 1998â€&quot;2002Trans. R. Soc."/>
 <result pre="Trop. Med. Hyg.200710116917516814821 49.FilippisAMet al.Isolation and characterization of wild type" exact="yellow fever" post="virus in cases temporally associated with 17DD vaccination during"/>
 <result pre="cases temporally associated with 17DD vaccination during an outbreak of" exact="yellow fever" post="in BrazilVaccine2004221073107815003633 50.SaraivaMet al.Historical analysis of the records of"/>
 <result pre="in BrazilVaccine2004221073107815003633 50.SaraivaMet al.Historical analysis of the records of sylvan" exact="yellow fever" post="in the State of Amazonas, Brazil, from 1996 to"/>
 <result pre="anti-yellow fever virus immunoglobulin m antibodies at 3â€&quot;4 years following" exact="yellow fever" post="vaccinationAm. J. Trop. Med. Hyg.2012871112111523109371 53.FergusonMCollaborative study to assess"/>
 <result pre="to assess the suitability of a candidate International Standard for" exact="yellow fever" post="vaccineBiologicals20043219520515572101 54.WietenRWet al.A single 17D yellow fever vaccination provides"/>
 <result pre="International Standard for yellow fever vaccineBiologicals20043219520515572101 54.WietenRWet al.A single 17D" exact="yellow fever" post="vaccination provides lifelong immunity; characterization of yellow-fever-specific neutralizing antibody"/>
 <result pre="T-cell responses after vaccinationPLoS ONE201611e014987126977808 55.Campi-AzevedoACet al.Short-lived immunity after 17DD" exact="yellow fever" post="single dose indicates that booster vaccination may be required"/>
 <result pre="in childFront. Immunol.201910219231616412 56.Lindsey, N. P. et al. Persistence of" exact="yellow fever" post="virus-specific neutralizing antibodies after vaccination among US travellers. J."/>
 <result pre="Travel Med.25, 10.1093/jtm/tay108 (2018). 57.RoukensAHEvan HalemKde VisserAWVisserLGLong-term protection after fractional-dose" exact="yellow fever" post="vaccination: follow-up study of a randomized, controlled, noninferiority trialAnn."/>
 <result pre="controlled, noninferiority trialAnn. Intern. Med.201816976176530476963 58.LopezPet al.Immunogenicity and safety of" exact="yellow fever" post="vaccine (stamaril) when administered concomitantly with a tetravalent dengue"/>
 <result pre="a randomized trialPediatr. Infect. Dis. J.2016351140114727254034 59.Roy ChowdhuryPet al.Immunogenicity of" exact="yellow fever" post="vaccine coadministered with MenAfriVac in healthy infants in Ghana"/>
 <result pre="in Ghana and MaliClin. Infect. Dis.201561S58659326553692 60.IdokoOTet al.Antibody responses to" exact="yellow fever" post="vaccine in 9 to 11-month-old Malian and Ghanaian childrenExpert"/>
 <result pre="Vaccines20191886787531269829 61.MuyanjaEet al.Immune activation alters cellular and humoral responses to" exact="yellow fever" post="17D vaccineJ. Clin. Investig.20141243147315824911151 62.AlbrechtPEnnisFASaltzmanEJKrugmanSPersistence of maternal antibody in"/>
 <result pre="of maternal antibody in infants beyond 12 months: mechanism of" exact="measles" post="vaccine failureJ. Pediatr.197791715718909009 63.VasconcelosPFCBarrettADTAre booster doses of yellow fever"/>
 <result pre="mechanism of measles vaccine failureJ. Pediatr.197791715718909009 63.VasconcelosPFCBarrettADTAre booster doses of" exact="yellow fever" post="vaccine needed?Lancet Infect. Dis.2019191275127631543248 64.DomingoCNiedrigMSafety of 17D derived yellow"/>
 <result pre="yellow fever vaccine needed?Lancet Infect. Dis.2019191275127631543248 64.DomingoCNiedrigMSafety of 17D derived" exact="yellow fever" post="vaccinesExpert Opin. Drug Saf.2009821122119309249 65.KongsgaardMet al.Adaptive immune responses to"/>
 <result pre="Drug Saf.2009821122119309249 65.KongsgaardMet al.Adaptive immune responses to booster vaccination against" exact="yellow fever" post="virus are much reduced compared to those after primary"/>
 <result pre="Rep.2017766228386132 66.BerkleySHealth securityâ€™s blind spotScience2018359107529590015 67.AdrienNet al.Differences between coverage of" exact="yellow fever" post="vaccine and the first dose of measles-containing vaccine: a"/>
 <result pre="vaccine: a desk review of global data sourcesVaccine2019374511451731266670 68.WietenRWet al.17D" exact="yellow fever" post="vaccine elicits comparable long-term immune responses in healthy individuals"/>
 <result pre="responses in healthy individuals and immune-compromised patientsJ. Infect.20167271372227017899 69.MartinsRMet al.17DD" exact="yellow fever" post="vaccine: a double blind, randomized clinical trial of immunogenicity"/>
</results>
